Get started
Author

Красаков Игорь Вячеславович

Observed names: I V Krasakov, I. Krasakov, I. V. Krasakov, I.V. Krasakov, Igor Krasakov, Igor V. Krasakov, Igor' V. Krasakov, И. В. Красаков, Красаков И. В., Красаков И.В.
ORCID: 0000-0001-6092-0659
Observed ORCID: 0000-0001-6092-0659
OpenAlex ID: A5070774960
[Sleep disorders in Parkinson's disease without dementia: a comparative randomized controlled study of melatonin and clonazepam].
2012 · I V Litvinenko, I V Krasakov, et al. · PubMed · 25
Impaired Sphingolipid Hydrolase Activities in Dementia with Lewy Bodies and Multiple System Atrophy
2022 · T. S. Usenko, K. A. Senkevich, et al. · Molecular Neurobiology · 23
Modern conception of the pathogenesis of neurodegenerative diseases and therapeutic strategy
2017 · I. V. Litvinenko, I. V. Krasakov, et al. · S S Korsakov Journal of Neurology and Psychiatry · 22
Polymorphism of autoimmune encephalitis
2019 · E.L. Polonskii, D.I. Skulyabin, et al. · Annals of Clinical and Experimental Neurology · 13
Tserebralnyye Narusheniya Obmena Zheleza Kak Osnova Razvitiya I Progressirovaniya Neyrodegenerativnykh Zabolevaniy
2018 · I.V. Litvinenko, I.V. Krasakov, et al. · Bulletin of the Russian Military Medical Academy · 7
PDF
Evaluation of gut microbiota in Parkinson’s disease using gas chromatography with mass spectrometric detection
2018 · I.V. Krasakov, I.V. Litvinenko, et al. · Annals of Clinical and Experimental Neurology · 6
PDF
[New approach to gait disorders therapy in late stages of Parkinson's disease].
2012 · I V Litvinenko, R R Khalimov, et al. · PubMed · 4
Current Concepts in the Pathogenesis of Neurodegenerative Diseases and Treatment Strategies
2019 · I. V. Litvinenko, I. V. Krasakov, et al. · Neuroscience and Behavioral Physiology · 3
1.050 Sleep Disorders in Patients With Parkinson's Disease
2011 · I. Krasakov, I.V. Litvinenko, et al. · Parkinsonism & Related Disorders · 3
Features of innate and adaptive immunity in patients with Parkinson's disease
2022 · Igor V. Krasakov, Nataliya I. Davydova, et al. · Annals of Clinical and Experimental Neurology · 2
PDF
The disorder of the iron metabolism as a possible mechanism for the development of neurodegeneration after new coronavirus infection of SARS-CoV-2
2021 · Igor V. Litvinenko, Igor V. Krasakov · Russian Military Medical Academy Reports · 2
PDF
Evaluation of Gut Microbiota in Parkinson’s Disease using Gas Chromatography with Mass Spectrometric Detection
2019 · I. V. Krasakov, I. V. Litvinenko, et al. · Human Physiology · 2
Sleep Disorders in Patients with Dementia in Parkinson’s Disease
2013 · I. V. Litvinenko, I. V. Krasakov, et al. · Neuroscience and Behavioral Physiology · 2
[The structural and functional neurovisualization in patients with epileptic seizures in cerebro-vascular diseases].
2008 · S N Bazilevich, M M Odinak, et al. · PubMed · 2
Challenges in diagnosis of fragile X-associated tremor/ataxia syndrome
2024 · Igor' V. Krasakov, Igor' V. Litvinenko, et al. · Russian Military Medical Academy Reports · 1
PDF
Role of short-chain fatty acids in the pathogenesis of Parkinson’s disease
2022 · Igor V. Krasakov, Igor V. Litvinenko, et al. · Russian Military Medical Academy Reports · 1
PDF
Ostraya Dekompensatsiya I Drugiye Neotlozhnyye Sostoyaniya Pri Bolezni Parkinsona
2019 · I.V. Litvinenko, I.V. Krasakov, et al. · Bulletin of the Russian Military Medical Academy · 1
[Sleep disorders in patients with dementia in Parkinson's disease].
2011 · I V Litvinenko, I V Krasakov, et al. · PubMed · 1
Serum markers of intestinal and blood-brain barrier permeability (zonulin and claudin-5) in patients with Parkinson’s disease
2026 · I.V. Krasakov, S.S. Aleksanin, et al. · S S Korsakov Journal of Neurology and Psychiatry
Мультимодальный подход к прогнозу прогрессирования болезни Паркинсона: от нейровизуализации к лаборатории
2026 · Литвиненко И. В., Красаков И. В. · cyberleninka.ru
Optimization of Botulinum Toxin Injections for Lower Camptocormia in Parkinson's Disease
2026 · Igor Krasakov · Toxicon
Navigation of Botulinum Neurotoxin Injections Using Ultrasound and Computed Tomography in Patients With Camptocormia
2026 · Aleksandr Kovalenko, Igor Krasakov · Toxicon
Type 28 spinocerebellar ataxia
2025 · I.V. Krasakov, I.V. Litvinenko, et al. · S S Korsakov Journal of Neurology and Psychiatry
Acquired non-Wilsonian hepatocerebral degeneration
2025 · I. V. Litvinenko, P. S. Dynin, et al. · Russian neurological Journal
The use of flexible botulinum toxin type A inter-injection intervals after removal of deep brain stimulation due to infection in patient with DYT-THAP1 (DYT6)
2023 · Igor' V. Krasakov, Igor' V. Litvinenko, et al. · Russian Military Medical Academy Reports
PDF
Works count: 35
Citation count: 123
H-index: 6
I10-index: 4
Year
Topic
Type